These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 12519922

  • 1. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
    Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P.
    N Engl J Med; 2003 Jan 09; 348(2):119-28. PubMed ID: 12519922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of multidrug-resistant tuberculosis in Turkey.
    Tahaoğlu K, Törün T, Sevim T, Ataç G, Kir A, Karasulu L, Ozmen I, Kapakli N.
    N Engl J Med; 2001 Jul 19; 345(3):170-4. PubMed ID: 11463011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ.
    Int J Tuberc Lung Dis; 2004 Mar 15; 8(3):361-8. PubMed ID: 15139476
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience.
    Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P.
    Soc Sci Med; 2004 Oct 15; 59(7):1529-39. PubMed ID: 15246180
    [Abstract] [Full Text] [Related]

  • 13. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
    Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ.
    Int J Tuberc Lung Dis; 2011 Oct 15; 15(10):1315-22. PubMed ID: 22283887
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.
    Kekkaku; 2001 Dec 15; 76(12):723-8. PubMed ID: 11806128
    [Abstract] [Full Text] [Related]

  • 17. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S.
    Int J Tuberc Lung Dis; 2012 Dec 15; 16(3):348-54. PubMed ID: 22640448
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
    Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC.
    Int J Tuberc Lung Dis; 2005 Feb 15; 9(2):175-80. PubMed ID: 15732737
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 15; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.